DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Insights from the dabigatran versus warfarin trial in patients with venous thromboembolism (the RE-COVER trial).

Author(s): Prandoni P, Taher A.

Affiliation(s): University of Padua, Department of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, Via Giustiniani 2, 35128 Padua, Italy. paoloprandoni@tin.it

Publication date & source: 2010, Expert Opin Pharmacother. , 11(6):1035-7

In this clinical trial evaluation, we revisit the RE-COVER study, a large multicenter, randomized, double-blind, noninferiority trial on patients with acute venous thromboembolism treated with dabigatran versus warfarin. Study design and key results are re-evaluated in the context of previous work and future perspectives.

Page last updated: 2013-02-10

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017